4.8 Article

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

期刊

MOLECULAR PSYCHIATRY
卷 15, 期 1, 页码 53-63

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2008.94

关键词

epidemiology; obsessive behavior; compulsive behavior; obsessive-compulsive disorder; National Comorbidity Survey Replication

资金

  1. National Institute of Mental Health (NIMH) Career Development Award [K01-MH076162, U01-MH60220, R01 MH070884]
  2. Medical Research Council of South Africa
  3. National Institute on Drug Abuse (NIDA)
  4. Substance Abuse and Mental Health Services Administration (SAMHSA)
  5. Robert Wood Johnson Foundation (RWJF) [044780]
  6. John W Alden Trust
  7. John D and Catherine T MacArthur Foundation
  8. Pfizer Foundation
  9. US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
  10. Fogarty International Center (FIRCA) [R03-TW006481]
  11. Pan American Health Organization
  12. Eli Lilly and Company
  13. Ortho-McNeil Pharmaceutical Inc.
  14. Glaxo SmithKline and Bristol-Myers Squibb
  15. FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER
  16. NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220, U13MH066849, R01MH070884, R13MH066849, R01MH069864, K01MH076162] Funding Source: NIH RePORTER
  17. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558, K05DA015799] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Despite significant advances in the study of obsessive-compulsive disorder (OCD), important questions remain about the disorder's public health significance, appropriate diagnostic classification, and clinical heterogeneity. These issues were explored using data from the National Comorbidity Survey Replication, a nationally representative survey of US adults. A subsample of 2073 respondents was assessed for lifetime Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV) OCD. More than one quarter of respondents reported experiencing obsessions or compulsions at some time in their lives. While conditional probability of OCD was strongly associated with the number of obsessions and compulsions reported, only small proportions of respondents met full DSM-IV criteria for lifetime (2.3%) or 12-month (1.2%) OCD. OCD is associated with substantial comorbidity, not only with anxiety and mood disorders but also with impulse-control and substance use disorders. Severity of OCD, assessed by an adapted version of the Yale-Brown Obsessive Compulsive Scale, is associated with poor insight, high comorbidity, high role impairment, and high probability of seeking treatment. The high prevalence of subthreshold OCD symptoms may help explain past inconsistencies in prevalence estimates across surveys and suggests that the public health burden of OCD may be greater than its low prevalence implies. Evidence of a preponderance of early onset cases in men, high comorbidity with a wide range of disorders, and reliable associations between disorder severity and key outcomes may have implications for how OCD is classified in DSM-V. Molecular Psychiatry (2010) 15, 53-63; doi: 10.1038/mp.2008.94; published online 26 August 2008

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据